Toxicity assessment of nanoparticles involves a combination of in vivo (animal studies) and in vitro (cell culture studies) methods. Advanced techniques such as high-throughput screening, omics technologies, and computational modeling are also used to predict toxicity. Regulatory agencies often require extensive safety evaluations before approving the use of nanomaterials in commercial products.
